0

    523696

    FORTISMLR

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    FORTIS MALAR HOSPITALS LIMITED Share Price Today

    Investment Returns

    Over 1 Month -3.47% Over 3 Months -11.05% Over 6 Months -12.22% Over 1 Year -26.30%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    FORTIS MALAR HOSPITALS LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 94.20
    • P/E Ratio (TTM) 22.30
    • Beta 0.82
    • Book Value / share 18.22
    • Return on equity 13.10%
    • EPS (TTM) 2.24
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.18
    info icon alternate text

    FORTIS MALAR HOSPITALS LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.31
    Net Profit 0.18
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.09
    EBITDA 0.22
    Effective Tax Rate (%) 22.72
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.53
    Net Profit -0.03
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.02
    EBITDA 0.12
    Effective Tax Rate (%) 125.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.31
    Net Profit 0.04
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.02
    EBITDA 0.21
    Effective Tax Rate (%) 80.95
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.37
    Net Profit 0.02
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.01
    EBITDA 0.15
    Effective Tax Rate (%) 86.66
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.30
    Net Profit 4.18
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 2.23
    EBITDA 4.31
    Effective Tax Rate (%) 3.01
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.51
    Net Profit 4.20
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 2.24
    EBITDA 4.79
    Effective Tax Rate (%) 12.31
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 2.13
    Net Profit 0.41
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.22
    EBITDA 0.60
    Effective Tax Rate (%) 30.50
    Particulars MAR 2024 (Values in Cr)
    Revenue 59.01
    Operating Expense 73.86
    Net Profit 47.28
    Net Profit Margin (%) 80.12
    Earnings Per Share (EPS) 25.23
    EBITDA 65.61
    Effective Tax Rate (%) 8.98
    Particulars MAR 2023 (Values in Cr)
    Revenue 85.95
    Operating Expense 99.59
    Net Profit -15.53
    Net Profit Margin (%) -18.06
    Earnings Per Share (EPS) -8.29
    EBITDA 11.14
    Effective Tax Rate (%) -119.49
    Particulars MAR 2022 (Values in Cr)
    Revenue 86.18
    Operating Expense 101.82
    Net Profit -8.31
    Net Profit Margin (%) -9.64
    Earnings Per Share (EPS) -4.43
    EBITDA 10.77
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 18.31
    ROE % 12.83
    ROCE % 14.65
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 16.11
    ROE % 0.56
    ROCE % 0.83
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 58.36
    ROE % -9.12
    ROCE % -3.24
    Total Debt to Total Equity 0.27
    EBITDA Margin 9.73
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 34.21
    ROE % -21.45
    ROCE % -0.75
    Total Debt to Total Equity 0.69
    EBITDA Margin 13.04
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 42.72
    ROE % -9.79
    ROCE % -1.19
    Total Debt to Total Equity 0.65
    EBITDA Margin 12.57
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 18.22
    ROE % 13.10
    ROCE % 14.94
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 15.97
    ROE % 0.59
    ROCE % 0.86
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 58.22
    ROE % -6.99
    ROCE % -1.52
    Total Debt to Total Equity 0.27
    EBITDA Margin 13.01
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 33.03
    ROE % -22.20
    ROCE % -0.81
    Total Debt to Total Equity 0.71
    EBITDA Margin 12.96
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 41.57
    ROE % -10.10
    ROCE % -1.25
    Total Debt to Total Equity 0.67
    EBITDA Margin 12.52
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 24.69
    Total Assets 37.60
    Total Liabilities 37.60
    Total Equity 34.34
    Share Outstanding 1
    Price to Book Ratio 2.29
    Return on Assets (%) 11.00
    Return on Capital (%) 12.05
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 17.79
    Total Assets 36.83
    Total Liabilities 36.83
    Total Equity 30.20
    Share Outstanding 1
    Price to Book Ratio 4.60
    Return on Assets (%) 1.06
    Return on Capital (%) 1.3
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 108.22
    Total Assets 115.87
    Total Liabilities 115.87
    Total Equity 109.46
    Share Outstanding 1
    Price to Book Ratio 0.80
    Return on Assets (%) 39.11
    Return on Capital (%) 41.4
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 9.43
    Total Assets 137.99
    Total Liabilities 137.99
    Total Equity 64.17
    Share Outstanding 1
    Price to Book Ratio 1.44
    Return on Assets (%) -11.21
    Return on Capital (%) -24.12
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 12.55
    Total Assets 160.91
    Total Liabilities 160.91
    Total Equity 80.13
    Share Outstanding 1
    Price to Book Ratio 1.39
    Return on Assets (%) -5.14
    Return on Capital (%) -10.32
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 24.26
    Total Assets 36.96
    Total Liabilities 36.96
    Total Equity 34.16
    Share Outstanding 1
    Price to Book Ratio 2.29
    Return on Assets (%) 11.36
    Return on Capital (%) 12.3
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 17.70
    Total Assets 36.57
    Total Liabilities 36.57
    Total Equity 29.96
    Share Outstanding 1
    Price to Book Ratio 4.60
    Return on Assets (%) 1.12
    Return on Capital (%) 1.37
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 106.10
    Total Assets 115.38
    Total Liabilities 115.38
    Total Equity 109.20
    Share Outstanding 1
    Price to Book Ratio 0.80
    Return on Assets (%) 40.97
    Return on Capital (%) 43.29
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 7.30
    Total Assets 135.69
    Total Liabilities 135.69
    Total Equity 61.95
    Share Outstanding 1
    Price to Book Ratio 1.44
    Return on Assets (%) -11.44
    Return on Capital (%) -25.07
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 10.48
    Total Assets 158.67
    Total Liabilities 158.67
    Total Equity 77.97
    Share Outstanding 1
    Price to Book Ratio 1.39
    Return on Assets (%) -5.23
    Return on Capital (%) -10.65
    Particulars MAR 2026 (Values in Cr)
    Net Income 4.72
    Cash from Operations -0.81
    Cash from Investing 0.45
    Cash from Financing 0.00
    Net change in Cash 1.08
    Free Cash Flow -0.81
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.56
    Cash from Operations -1.73
    Cash from Investing -29.09
    Cash from Financing -79.65
    Net change in Cash -107.20
    Free Cash Flow -1.73
    Particulars MAR 2024 (Values in Cr)
    Net Income 50.00
    Cash from Operations -2.27
    Cash from Investing 119.70
    Cash from Financing -10.85
    Net change in Cash 101.54
    Free Cash Flow 0.02
    Particulars MAR 2023 (Values in Cr)
    Net Income -7.00
    Cash from Operations 5.52
    Cash from Investing 0.49
    Cash from Financing -12.65
    Net change in Cash -6.54
    Free Cash Flow 7.40
    Particulars MAR 2022 (Values in Cr)
    Net Income -8.26
    Cash from Operations 7.56
    Cash from Investing 8.23
    Cash from Financing -10.10
    Net change in Cash 4.97
    Free Cash Flow 8.96
    Particulars MAR 2026 (Values in Cr)
    Net Income 4.79
    Cash from Operations -1.19
    Cash from Investing 0.45
    Cash from Financing 0.00
    Net change in Cash 0.74
    Free Cash Flow -1.19
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.58
    Cash from Operations -1.49
    Cash from Investing -27.29
    Cash from Financing -79.65
    Net change in Cash -105.17
    Free Cash Flow -1.49
    Particulars MAR 2024 (Values in Cr)
    Net Income 51.94
    Cash from Operations -2.20
    Cash from Investing 119.62
    Cash from Financing -10.85
    Net change in Cash 101.55
    Free Cash Flow 0.09
    Particulars MAR 2023 (Values in Cr)
    Net Income -7.07
    Cash from Operations 5.51
    Cash from Investing 0.43
    Cash from Financing -12.65
    Net change in Cash -6.60
    Free Cash Flow 7.39
    Particulars MAR 2022 (Values in Cr)
    Net Income -8.30
    Cash from Operations 7.47
    Cash from Investing 8.17
    Cash from Financing -10.10
    Net change in Cash 4.87
    Free Cash Flow 8.88
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8921.50 68.63 13.53 128277.48 6680.00 9326.80
    SHREE PACETRONIX LTD. 144.40 17.23 3.04 54.15 74.25 283.15
    TRANSGENE BIOTEK LTD. 3.13 0.00 2.83 23.72 1.83 5.17
    VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8921.50 91.18 12.87 128277.48 6680.00 9326.80
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.49 0.00 -9.36 28.75 30.30 57.48
    KOVAI MEDICAL CENTER & HOSPITA 5866.65 26.08 4.86 6418.12 5010.00 6725.00

    FORTIS MALAR HOSPITALS LIMITED shareholding pattern

    Holding
    37.22%
    62.7%
    0.07%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    FORTIS MALAR HOSPITALS LIMITED Technicals Summary

    50.28 0.66 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 50.10
    • 26 Days 50.80
    • 10 Days 50.20
    • 50 Days 51.60
    • 12 Days 50.20
    • 100 Days 53.10
    • 20 Days 50.50
    • 200 Days 55.80
    50.34 PIVOT
    First Support 49.23 First Resistance 51.06 Second Support 48.51 Second Resistance 52.17 Third Support 47.40 Third Resistance 52.89
    RSI 43.14 ADX 35.72 MACD -0.52 Williams % R -53.95 Commodity Channel Index (CCI) -8.99
    Date 2026-08-04 Week 4548.00 Same Day 3185.00 Month 4759.00
    1 Year 0.83 3 Year 0.61
    Over 1 Month
    -3.47% down
    Over 1 Year
    -26.30% down
    Over 3 Months
    -11.05% down
    Over 3 Years
    -4.91% down
    Over 6 Months
    -12.22% down
    Over 5 Years
    -4.89% down

    FORTIS MALAR HOSPITALS LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2024 2.5 Final 24 Jul 2024 Equity shares
    23 Apr 2024 40.0 Interim 23 Apr 2024 Equity shares
    14 Sep 2015 0.5 Final 16 Sep 2015 Equity shares
    19 Sep 2013 0.5 Interim 20 Sep 2013 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Fortis Malar Hospitals Ltd?

    Answer Field

    Fortis Malar Hospitals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 50.28 as on Aug 05 2026 03:27 PM.

    What is the Market Cap of Fortis Malar Hospitals Ltd Share?

    Answer Field

    The market cap of Fortis Malar Hospitals Ltd for NSE ₹ 0.00 & for BSE ₹ 94.20 as on Aug 05 2026 03:27 PM.

    What is the 52 Week High and Low of Fortis Malar Hospitals Ltd?

    Answer Field

    The 52 Week High and Low of Fortis Malar Hospitals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 76.00 and ₹ 40.75.

    What is 1 year return for Fortis Malar Hospitals Ltd?

    Answer Field

    The 1 year returns on the stock has been -26.30%.

    What is the P/E Ratio of Fortis Malar Hospitals Ltd Share?

    Answer Field

    As on Aug 05 2026 03:27 PM the price-to-earnings (PE) ratio for Fortis Malar Hospitals Ltd share is 22.30.

    What is the PB ratio of Fortis Malar Hospitals Ltd Share?

    Answer Field

    As on Aug 05 2026 03:27 PM, the price-to-book (PB) ratio for Fortis Malar Hospitals Ltd share is 18.22.

    How to Buy Fortis Malar Hospitals Ltd Share?

    Answer Field

    You can trade in Fortis Malar Hospitals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Fortis Malar Hospitals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Fortis Malar Hospitals Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Fortis Malar Hospitals Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |